Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.

Targher G, Byrne CD.

Metab Syndr Relat Disord. 2015 Feb 25. [Epub ahead of print]

PMID:
25714786
2.

An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality.

Sung KC, Ryu S, Wild SH, Byrne CD.

Heart. 2015 Apr 1;101(7):553-8. doi: 10.1136/heartjnl-2014-306784. Epub 2015 Jan 30.

PMID:
25637367
3.

Composition of dietary macronutrient intake is not associated with prevalence of coronary artery calcification in healthy Korean adults.

Sung KC, Sung E, Byrne CD, Kim YB, Ahn CW, Chung HK.

Ann Nutr Metab. 2015;66(1):36-43. doi: 10.1159/000369563. Epub 2014 Dec 13.

PMID:
25531976
4.

The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia.

Pears R, Griffin M, Watson M, Wheeler R, Hilder D, Meeson B, Bacon S, Byrne CD.

Open Heart. 2014 Aug 12;1(1):e000015. doi: 10.1136/openhrt-2013-000015. eCollection 2014.

5.

Application of new guidelines for the primary prevention of atherosclerotic cardiovascular disease in a korean population.

Kim NH, So MS, Kang JG, Cho DS, Byrne CD, Lee SJ, Sung KC.

J Atheroscler Thromb. 2015 Mar 23;22(3):293-303. doi: 10.5551/jat.26682. Epub 2014 Oct 4.

6.

Evaluation of bioelectrical impedance analysis for identifying overweight individuals at increased cardiometabolic risk: a cross-sectional study.

Lamb MJ, Byrne CD, Wilson JF, Wild SH.

PLoS One. 2014 Sep 22;9(9):e106134. doi: 10.1371/journal.pone.0106134. eCollection 2014.

7.

CKD and nonalcoholic fatty liver disease.

Targher G, Chonchol MB, Byrne CD.

Am J Kidney Dis. 2014 Oct;64(4):638-52. doi: 10.1053/j.ajkd.2014.05.019. Epub 2014 Jul 30. Review.

PMID:
25085644
8.

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.

Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L, Moyses HE, Calder PC, Byrne CD; WELCOME Study.

Hepatology. 2014 Oct;60(4):1211-21.

PMID:
25043514
9.

Randomised controlled feasibility trial of a web-based weight management intervention with nurse support for obese patients in primary care.

Yardley L, Ware LJ, Smith ER, Williams S, Bradbury KJ, Arden-Close EJ, Mullee MA, Moore MV, Peacock JL, Lean ME, Margetts BM, Byrne CD, Hobbs RF, Little P.

Int J Behav Nutr Phys Act. 2014 May 21;11:67. doi: 10.1186/1479-5868-11-67.

10.

Daily energy expenditure, cardiorespiratory fitness and glycaemic control in people with type 1 diabetes.

Valletta JJ, Chipperfield AJ, Clough GF, Byrne CD.

PLoS One. 2014 May 14;9(5):e97534. doi: 10.1371/journal.pone.0097534. eCollection 2014.

11.

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.

Byrne CD, Targher G.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1155-61. doi: 10.1161/ATVBAHA.114.303034. Epub 2014 Apr 17. Review.

PMID:
24743428
12.

Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.

Targher G, Mantovani A, Pichiri I, Mingolla L, Cavalieri V, Mantovani W, Pancheri S, Trombetta M, Zoppini G, Chonchol M, Byrne CD, Bonora E.

Diabetes Care. 2014 Jun;37(6):1729-36. doi: 10.2337/dc13-2704. Epub 2014 Apr 2.

PMID:
24696459
13.

Towards a personalised diagnosis of type 2 diabetes.

Wild SH, Byrne CD.

Lancet Diabetes Endocrinol. 2013 Sep;1(1):6-7. doi: 10.1016/S2213-8587(13)70010-X. Epub 2013 Feb 21. No abstract available.

PMID:
24622254
14.

Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link?

Targher G, Byrne CD.

Endocrine. 2014 Sep;47(1):3-4. doi: 10.1007/s12020-014-0220-3. Epub 2014 Mar 5. No abstract available.

PMID:
24595898
15.

Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.

Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Pichiri I, Mantovani A, Zoppini G, Bonora E, Barbieri E, Byrne CD.

Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):663-9. doi: 10.1016/j.numecd.2014.01.005. Epub 2014 Jan 21.

PMID:
24594085
16.

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G.

World J Gastroenterol. 2014 Feb 21;20(7):1724-45. doi: 10.3748/wjg.v20.i7.1724. Review.

17.

C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians.

Sung KC, Ryu S, Chang Y, Byrne CD, Kim SH.

Eur Heart J. 2014 Jul 14;35(27):1809-16. doi: 10.1093/eurheartj/ehu059. Epub 2014 Feb 25.

PMID:
24569028
18.

Design and rationale of the WELCOME trial: A randomised, placebo controlled study to test the efficacy of purified long chainomega-3 fatty acid treatment in non-alcoholic fatty liver disease [corrected].

Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Calder PC, Byrne CD; WELCOME Trial Investigators.

Contemp Clin Trials. 2014 Mar;37(2):301-11. doi: 10.1016/j.cct.2014.02.002. Epub 2014 Feb 18. Erratum in: Contemp Clin Trials. 2014 May;38(1):156.

PMID:
24556343
19.

Glucose metabolism in adult survivors of severe acute malnutrition.

Francis-Emmanuel PM, Thompson DS, Barnett AT, Osmond C, Byrne CD, Hanson MA, Gluckman PD, Forrester TE, Boyne MS.

J Clin Endocrinol Metab. 2014 Jun;99(6):2233-40. doi: 10.1210/jc.2013-3511. Epub 2014 Feb 11.

PMID:
24517147
20.

High-sensitivity C-reactive protein is associated with the presence of coronary artery calcium in subjects with normal blood pressure but not in subjects with hypertension.

Sung JW, Lee SH, Byrne CD, Chung PW, Won YS, Sung KC.

Arch Med Res. 2014 Feb;45(2):170-6. doi: 10.1016/j.arcmed.2014.01.003. Epub 2014 Feb 4.

PMID:
24508289
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk